Detlev Ganten
Presidente presso Charité - Universitätsmedizin Berlin
Posizioni attive di Detlev Ganten
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Charité - Universitätsmedizin Berlin | Presidente | 01/01/2005 | - |
| Max Planck Institute of Colloids & Interfaces | Presidente | 01/01/2010 | - |
| GlycoUniverse GmbH & Co KGaA | Direttore/Membro del Consiglio | - | - |
Eckert & Ziegler AG
 Eckert & Ziegler AG Hospital/Nursing ManagementHealth Services Eckert & Ziegler AG is a leading specialist in isotope-related components for nuclear medicine and radiation therapy. The private company has a global presence of subsidiaries in several regions and is based in Berlin, DE. With nearly 1,000 employees, the German company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. The CEO of the company is Andreas Eckert. | Direttore/Membro del Consiglio | - | - |
| World Health Summit | Presidente | 01/01/2009 | - |
| Max Planck Institute of Molecular Plant Physiology | Presidente | - | - |
Storia della carriera di Detlev Ganten
Precedenti posizioni note di Detlev Ganten
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ECKERT & ZIEGLER SE | Direttore/Membro del Consiglio | 20/05/2009 | 29/05/2019 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
 Max-Delbrück-Centrum für Molekulare Medizin (MDC) Miscellaneous Commercial ServicesCommercial Services Max-Delbrück-Centrum für Molekulare Medizin operates as a biomedical research institute. It engages in translating discoveries from molecular research into applications to improve the prevention, diagnosis, and treatment of major human diseases. The company was founded in 1992 and is headquartered in Berlin, Germany. | Direttore/Membro del Consiglio | 01/01/1991 | 01/01/2004 |
| Université PSL | Direttore/Membro del Consiglio | - | - |
Formazione di Detlev Ganten
| McGill University | Doctorate Degree |
| Eberhard Karls Universität Tübingen | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Germania | 10 |
| Canada | 2 |
| Francia | 2 |
Posizioni
| Director/Board Member | 5 |
| Chairman | 3 |
| President | 1 |
Settori
| Consumer Services | 6 |
| Health Technology | 2 |
| Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ECKERT & ZIEGLER SE | Health Technology |
| Aziende private | 5 |
|---|---|
| GlycoUniverse GmbH & Co KGaA | |
Eckert & Ziegler AG
Eckert & Ziegler AG Hospital/Nursing ManagementHealth Services Eckert & Ziegler AG is a leading specialist in isotope-related components for nuclear medicine and radiation therapy. The private company has a global presence of subsidiaries in several regions and is based in Berlin, DE. With nearly 1,000 employees, the German company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. The CEO of the company is Andreas Eckert. | Health Services |
| World Health Summit | |
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
Max-Delbrück-Centrum für Molekulare Medizin (MDC) Miscellaneous Commercial ServicesCommercial Services Max-Delbrück-Centrum für Molekulare Medizin operates as a biomedical research institute. It engages in translating discoveries from molecular research into applications to improve the prevention, diagnosis, and treatment of major human diseases. The company was founded in 1992 and is headquartered in Berlin, Germany. | Commercial Services |
| Max Planck Institute of Molecular Plant Physiology |
- Borsa valori
- Insiders
- Detlev Ganten
- Esperienza
